215
Views
1
CrossRef citations to date
0
Altmetric
Research

Evaluation of the knowledge, practices, and attitudes of community pharmacists towards adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a cross-sectional study

ORCID Icon, &
Article: 132 | Received 26 Jul 2023, Accepted 17 Oct 2023, Published online: 11 Mar 2024

References

  • Azizah MM, Ahdab NK, Ruba AM, Jumana SA, Bushra YA, Samar AAEvaluation of the community pharmacists’ performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi ArabiaSaudi Med J2020418849 10.15537/smj.2020.8.25221
  • Kim HJ, Yang YM, Choi EJUse patterns of over-the-counter (OTC) medications and perspectives on OTC medications among Korean adult patients with chronic diseases: gender and age differencesPatient Prefer Adherence20181215971606 10.2147/PPA.S173873 30214162 6118289
  • El-Nimr NA, Wahdan IM, Wahdan AM, Kotb RESelf-medication with drugs and complementary and alternative medicines in Alexandria, Egypt: prevalence, patterns and determinantsEast Mediterr Health J2015214256265 1:STN:280:DC%2BC2MbjvF2ktg%3D%3D 10.26719/2015.21.4.256 26077520
  • Oliviu VA-K AGAAdverse effects and drug interactions of the non-steroidal anti-inflammatory drugsNonsteroidal anti-inflammatory drugs2017RijekaIntechOpenCh. 3
  • Harirforoosh S, Asghar W, Jamali FAdverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complicationsJ Pharm Pharm Sci2013165821847 10.18433/J3VW2F 24393558
  • Choudhury D, Ahmed ZDrug-associated renal dysfunction and injuryNat Clin Pract Nephrol2006228091 1:CAS:528:DC%2BD28XmvV2nt7Y%3D 10.1038/ncpneph0076 16932399
  • Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman SExceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen usersPharmacoepidemiol Drug Saf2018273322331 1:CAS:528:DC%2BC1cXkt12rtrg%3D 10.1002/pds.4391 29372579
  • Grezy-Chabardes C, Fournier JP, Dupouy J, Poutrain JC, Oustric SPatients' knowledge about analgesic-antipyretic medications purchased in community pharmacies: a descriptive studyJ Pain Palliat Care Pharmacother2015294334340 10.3109/15360288.2015.1082007 26524132
  • Mullan J, Weston KM, Bonney A, Burns P, Mullan J, Rudd RConsumer knowledge about over-the-counter NSAIDs: they don't know what they don't knowAust N Z J Public Health2017412210214 10.1111/1753-6405.12589 27774735
  • Wilcox CM, Cryer B, Triadafilopoulos GPatterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugsJ Rheumatol2005321122182224 1:CAS:528:DC%2BD2MXht12ltbjJ 16265706
  • Owusu YB, Elkhalifa WH, Awaisu A, Kheir NAssessment of Qatar community pharmacists' competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDsSaudi Pharm J2022301013961404 1:CAS:528:DC%2BB38Xit1amsLjP 10.1016/j.jsps.2022.06.011 36387344 9649341
  • Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul NEvaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in ThailandPrim Health Care Res Dev2018196598604 10.1017/S1463423618000142 29551098
  • Abdel-Latif MM, Hassan SB, Sabra KThe status of community pharmacy in Egypt: are community pharmacies ready to deliver clinical pharmacy services at the national level?Bull Pharm Sci Assiut202144199110 10.21608/bfsa.2021.174135
  • Wu M-J, Zhao K, Fils-Aime FResponse rates of online surveys in published research: a meta-analysisComput Hum Behav Rep20227 10.1016/j.chbr.2022.100206
  • Rajiah K, Sivarasa S, Maharajan MKImpact of pharmacists' interventions and patients' decision on health outcomes in terms of medication adherence and quality use of medicines among patients attending community pharmacies: a systematic reviewInt J Environ Res Public Health2021 10.3390/ijerph18094392 33918990 8122322
  • Abougalambou SSI, AbaAlkhail H, Abougalambou ASThe knowledge, attitude and practice among diabetic patient in central region of Saudi ArabiaDiabetes Metab Syndr201913529752981 10.1016/j.dsx.2019.07.049 31539765
  • Bidaut-Russell M, Gabriel SEAdverse gastrointestinal effects of NSAIDs: consequences and costsBest Pract Res Clin Gastroenterol2001155739753 1:CAS:528:DC%2BD38Xhs1KlsA%3D%3D 10.1053/bega.2001.0232 11566038
  • Babelghaith SD, Alarifi MN, Wajid S, Alhawassi TM, Alqahtani SK, Alghadeer SMKnowledge of patients on safe medication use in relation to nonsteroidal anti-inflammatory drugsSaudi J Anaesth2019132106111 10.4103/sja.SJA_557_18 31007655 6448436
  • Parekh S, Livingstone C, Jani YHEvaluation of the England Community Pharmacy Quality Scheme (2018–2019 and 2019–2020) in reducing harm from NSAIDs in older patientsBMJ Open Qual.2023 10.1136/bmjoq-2022-002002 36593072 9809222
  • Mangum SA, Kraenow KR, Narducci WAIdentifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projectsJ Am Pharm Assoc (1996).20034315055 10.1331/10865800360467042
  • Teichert M, Griens F, Buijs E, Wensing M, De Smet PAEffectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug usersPharmacoepidemiol Drug Saf2014234382389 1:CAS:528:DC%2BC2cXlvFOqsrg%3D 10.1002/pds.3587 24535837
  • Pai ABKeeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patientsJ Am Pharm Assoc2015551e15e25 10.1331/JAPhA.2015.15506
  • Jang SM, Cerulli J, Grabe DW, Fox C, Vassalotti JA, Prokopienko AJ, et al.Peer reviewed: NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011Prevent Chron Dis.2014 10.5888/pcd11.140298
  • Shrestha R, Palaian S, Sapkota B, Shrestha S, Khatiwada AP, Shankar PRA nationwide exploratory survey assessing perception, practice, and barriers toward pharmaceutical care provision among hospital pharmacists in NepalSci Rep202212116590 10.1038/s41598-022-16653-x 36198682 9532804
  • Seston EM, Schafheutle EI, Willis SC, Karolczak-Bayatti M, Lane J, White S, et al.Preparing pharmacists for the Community Pharmacist Consultation Service: a questionnaire surveyInt J Pharm Pract20223113237 10.1093/ijpp/riac076
  • Mohamed Ibrahim OHJAssessment of Egyptian pharmacists’ attitude, behaviors, and preferences related to continuing educationInt J Clin Pharm201234358363 10.1007/s11096-012-9616-4 22354853
  • Silcock J, Moffett JK, Edmondson H, Waddell G, Burton AKDo community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain?BMC Musculoskelet Disord2007810 10.1186/1471-2474-8-10 17266748 1796877